Labcorp Holdings Inc. (LH) stock
LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$372.46+1.98 (+0.53%)
Close on Nov 16, 2026Market cap $30.24BP/E 30.6Yield 0.77%
Labcorp cash
Cash and short-term investments held at the end of each period.
Labcorp's cash was $261.80M at Sep 30, 2026. For fiscal 2025 it was $532.30M, down 65.0% from the year before. Over ten years it grew -2.9% a year on average. The highest annual figure on record is $1.52B in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $532.30M | -65.0% |
| FY2024 | Dec 31, 2024 | $1.52B | +182.9% |
| FY2023 | Dec 31, 2023 | $536.80M | +67.4% |
| FY2022 | Dec 31, 2022 | $320.60M | -76.8% |
| FY2021 | Dec 31, 2021 | $1.38B | +4.6% |
| FY2020 | Dec 31, 2020 | $1.32B | +291.3% |
| FY2019 | Dec 31, 2019 | $337.50M | -20.9% |
| FY2018 | Dec 31, 2018 | $426.80M | +34.8% |
| FY2017 | Dec 31, 2017 | $316.60M | -27.0% |
| FY2016 | Dec 31, 2016 | $433.60M | -39.5% |
| FY2015 | Dec 31, 2015 | $716.40M | +23.5% |
| FY2014 | Dec 31, 2014 | $580.00M | +43.6% |
| FY2013 | Dec 31, 2013 | $404.00M | 0.0% |
| FY2012 | Dec 31, 2012 | $404.00M | -13.5% |
| FY2011 | Dec 31, 2011 | $466.80M | +193.0% |
| FY2010 | Dec 31, 2010 | $159.30M | +7.3% |
| FY2009 | Dec 31, 2009 | $148.50M | -32.4% |
| FY2008 | Dec 31, 2008 | $219.70M | +289.5% |
| FY2007 | Dec 31, 2007 | $56.40M | +9.5% |
| FY2006 | Dec 31, 2006 | $51.50M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $261.80M | -56.2% |
| Q2 FY2026 | Jun 30, 2026 | $141.80M | -78.1% |
| Q1 FY2026 | Mar 31, 2026 | $981.10M | +165.6% |
| Q4 FY2025 | Dec 31, 2025 | $532.30M | -65.0% |
| Q3 FY2025 | Sep 30, 2025 | $598.10M | -60.6% |
| Q2 FY2025 | Jun 30, 2025 | $647.30M | +144.2% |
| Q1 FY2025 | Mar 31, 2025 | $369.40M | +272.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.52B | +182.9% |
| Q3 FY2024 | Sep 30, 2024 | $1.52B | +108.4% |
| Q2 FY2024 | Jun 30, 2024 | $265.10M | -86.3% |
| Q1 FY2024 | Mar 31, 2024 | $99.30M | -74.8% |
| Q4 FY2023 | Dec 31, 2023 | $536.80M | +67.4% |
| Q3 FY2023 | Sep 30, 2023 | $727.90M | +77.6% |
| Q2 FY2023 | Jun 30, 2023 | $1.93B | +97.3% |
| Q1 FY2023 | Mar 31, 2023 | $393.90M | -68.1% |
| Q4 FY2022 | Dec 31, 2022 | $320.60M | -76.8% |
| Q3 FY2022 | Sep 30, 2022 | $409.90M | -79.9% |
| Q2 FY2022 | Jun 30, 2022 | $978.30M | -50.2% |
| Q1 FY2022 | Mar 31, 2022 | $1.23B | -34.8% |
| Q4 FY2021 | Dec 31, 2021 | $1.38B | +4.6% |
| Q3 FY2021 | Sep 30, 2021 | $2.04B | +205.2% |
| Q2 FY2021 | Jun 30, 2021 | $1.96B | +252.5% |
| Q1 FY2021 | Mar 31, 2021 | $1.89B | +484.3% |
| Q4 FY2020 | Dec 31, 2020 | $1.32B | +291.3% |
| Q3 FY2020 | Sep 30, 2020 | $667.20M | +84.8% |
| Q2 FY2020 | Jun 30, 2020 | $557.00M | +109.9% |
| Q1 FY2020 | Mar 31, 2020 | $323.60M | -7.2% |
| Q4 FY2019 | Dec 31, 2019 | $337.50M | -20.9% |
| Q3 FY2019 | Sep 30, 2019 | $361.10M | -59.5% |
| Q2 FY2019 | Jun 30, 2019 | $265.40M | -70.3% |
| Q1 FY2019 | Mar 31, 2019 | $348.80M | -3.6% |
| Q4 FY2018 | Dec 31, 2018 | $426.80M | +34.8% |
| Q3 FY2018 | Sep 30, 2018 | $892.60M | +118.1% |
| Q2 FY2018 | Jun 30, 2018 | $892.60M | +197.6% |
| Q1 FY2018 | Mar 31, 2018 | $361.80M | -1.0% |
| Q4 FY2017 | Dec 31, 2017 | $316.60M | -27.0% |
| Q3 FY2017 | Sep 30, 2017 | $409.30M | – |
| Q2 FY2017 | Jun 30, 2017 | $299.90M | – |
| Q1 FY2017 | Mar 31, 2017 | $365.50M | – |
| Q4 FY2016 | Dec 31, 2016 | $433.60M | – |
See a number that looks wrong?